TC |
Stat |
Stk |
Ins |
Fil |
+d |
+w |
+m |
+q |
+h |
+y |
avg |
|---|
Filing Date |
T Date |
Ticker |
Issuer | Inc | Sector |
Ind | Industry |
Owner |
oSt |
Rel |
Title |
T |
TVal |
Price |
L |
Qty |
oc |
Own |
H |
r2y |
r1y |
r6m |
r3m |
r6w |
r3w |
r7d |
r3d |
f1d |
f1w |
f1m |
f3m |
f6m |
f1y |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
9/19/17 16:46 | 9/17/17 | NVLN | Novelion Therapeutics Inc. | A1 | Health | Drug | Pharmaceutical Preparations | Harshbarger Benjamin | A1 | O | GC | M.d | 0 | 0.00 | 0 | 0 | 25 | 2 | D | ||||||||||||||
5/17/17 16:02 | 5/15/17 | NVLN | Novelion Therapeutics Inc. | A1 | Health | Drug | Pharmaceutical Preparations | Harshbarger Benjamin | A1 | O | GC | M.d | 0 | 0.00 | 1 | 1 | 98 | 1 | D | -49 | 24 | 10 | -12 | -13 | -8 | -4 | -1 | ||||||
5/11/17 16:01 | 5/9/17 | NVLN | Novelion Therapeutics Inc. | A1 | Health | Drug | Pharmaceutical Preparations | Harshbarger Benjamin | A1 | O | GC | M.d | 0 | 0.00 | 1 | 1 | 307 | 1 | D | -49 | 18 | 18 | -10 | -14 | -8 | -6 | -2 | 1 | |||||
4/4/17 16:02 | 4/1/17 | NVLN | Novelion Therapeutics Inc. | A1 | Health | Drug | Pharmaceutical Preparations | Harshbarger Benjamin | A1 | O | GC | M.d | 0 | 0.00 | 1 | 0 | 61 | 0 | D | -44 | 4 | 5 | 29 | 0 | -5 | 2 | -1 | -1 | -1 | -9 | |||
9/20/16 16:03 | 4/1/16 | AEGR | Aegerion Pharmaceuticals, Inc. | DE | Health | Drug | Pharmaceutical Preparations | Harshbarger Benjamin | MA | O | GC | M.dm | 0 | 0.00 | 0 | 3 | 2 | D | -95 | -89 | -54 | 15 | 21 | 13 | 21 | 7 | -2 | 15 | -19 |
| D | Derivative transaction in filing (usually option exercise) |
| M | Multiple transactions in filing; earliest reported transaction date and weighted average transaction price |
| A | Amended filing |
| E | Error detected in filing |
| S - Sale | Sale of securities on an exchange or to another person |
| S - Sale+OE | Sale of securities on an exchange or to another person (after option exercise) |
| F - Tax | Payment of exercise price or tax liability using portion of securities received from the company |
| P - Purchase | Purchase of securities on an exchange or from another person |